Amyloïdose
Description
Veille informationnelle portant sur l'amyloïdose
Sujets couverts
Amyloïdose
Atteintes cardiovasculaires
Diagnostic et évaluation
Interventions et pronostic
Expériences des patients et des institutions
Sources
PubMed
Fréquence
Mensuelle
Bibliothécaire responsable
Caroline Dion
caroline.dion.chum@ssss.gouv.qc.ca
Amyloïdose
-
Localized Tracheobronchial Transthyretin Amyloidosis Diagnosed After Hemoptysis: A Case Report
Le 17 octobre 2026
Respirol Case Rep. 2026 Oct 6;14(10):e70781. doi: 10.1002/rcr2.70781. eCollection 2026 Oct. ABSTRACT Pulmonary involvement in transthyretin amyloidosis (ATTR) is rare, and tracheobronchial…
-
A rare case of pulmonary amyloidosis with lymphocytic interstitial pneumonia in a patient with systemic lupus erythematosus
Le 17 octobre 2026
Clin Exp Rheumatol. 2026 Oct 6. doi: 10.55563/clinexprheumatol/g3t8q2. Online ahead of print. NO ABSTRACT PMID: 42873692 | DOI: 10.55563/clinexprheumatol/g3t8q2
-
Localised immunoglobulin light chain amyloidosis of the rectum: a rare endoscopic finding
Le 17 octobre 2026
BMJ Case Rep. 2026 Oct 14;19(10):e274860. doi: 10.1136/bcr-2026-274860. NO ABSTRACT PMID: 42875105 | DOI: 10.1136/bcr-2026-274860
-
Cerebral Amyloid Angiopathy Caused by Immunoglobulin Light Chain Amyloidosis
Le 17 octobre 2026
Can J Neurol Sci. 2026 Oct 15:1-3. doi: 10.1017/cjn.2026.10702. Online ahead of print. NO ABSTRACT PMID: 42878195 | DOI: 10.1017/cjn.2026.10702
-
Molecular Pathogenesis of Cerebral Amyloid Angiopathy in Alzheimer's Disease: The Role of the Central Fibrinolytic Cascade at the Neurovascular Unit
Le 17 octobre 2026
Mol Neurobiol. 2026 Oct 15;63(1):969. doi: 10.1007/s12035-026-06263-3. ABSTRACT Alzheimer's disease (AD) is increasingly recognized as a multifactorial neurodegenerative disorder involving complex…
-
Amyloid goitre in cryptogenic AA amyloidosis: contrasting thyroid phenotypes and proteomic typing
Le 17 octobre 2026
QJM. 2026 Oct 10:hcag290. doi: 10.1093/qjmed/hcag290. Online ahead of print. NO ABSTRACT PMID: 42860057 | DOI: 10.1093/qjmed/hcag290
-
Aggressive mediastinal amyloidosis mimicking malignancy: a case report
Le 17 octobre 2026
Int J Surg Case Rep. 2026 Sep 1;138(10):4161-4166. doi: 10.1097/RC9.0000000000000925. eCollection 2026 Oct. ABSTRACT INTRODUCTION: Amyloidosis is characterized by extracellular protein fibril…
-
Proteomic dysregulation associated with cerebral amyloid angiopathy
Le 17 octobre 2026
Alzheimers Dement. 2026 Oct;22(10):e71901. doi: 10.1002/alz.71901. ABSTRACT INTRODUCTION: Cerebral amyloid angiopathy (CAA) is characterized by impaired vascular amyloid-β clearance, distinct from…
-
Amyloid Neuropathies
Le 17 octobre 2026
Continuum (Minneap Minn). 2026 Oct;32(5):1461-1485. doi: 10.1212/cont.0000000000001752. Epub 2026 Oct 2. ABSTRACT OBJECTIVE: This article reviews the pathophysiology, epidemiology, and clinical…
-
Disease Progression in Iatrogenic Cerebral Amyloid Angiopathy
Le 17 octobre 2026
Neurology. 2026 Oct 27;107(8):e218511. doi: 10.1212/WNL.0000000000218511. Epub 2026 Sep 29. ABSTRACT BACKGROUND AND OBJECTIVES: Iatrogenic cerebral amyloid angiopathy (iCAA), likely caused by…
Atteintes cardiovasculaires
-
The Arrhythmic Burden of Cardiac Amyloidosis: A Comprehensive Review
Le 17 octobre 2026
Heart Views. 2026 Aug 25;27:5. doi: 10.4103/heartviews.heartviews_167_25. eCollection 2026. ABSTRACT Cardiac amyloidosis (CA) represents a growing etiology of heart failure (HF) and arrhythmogenesis,…
-
Multimodal artificial intelligence to predict cardiomyopathy development in hereditary transthyretin amyloidosis
Le 17 octobre 2026
Open Heart. 2026 Oct 9;13(2):e004243. doi: 10.1136/openhrt-2026-004243. NO ABSTRACT PMID: 42869491 | DOI: 10.1136/openhrt-2026-004243
-
Arrhythmias in patients with transthyretin cardiac amyloidosis and the impact of contemporary disease-modifying therapies
Le 17 octobre 2026
J Cardiovasc Med (Hagerstown). 2026 Oct 1;27(10):786-797. doi: 10.2459/JCM.0000000000001944. Epub 2026 Oct 2. ABSTRACT Transthyretin cardiac amyloidosis (ATTR-CM) is an increasingly recognized…
-
Screening for patients at risk for cardiac amyloidosis via electronic health records: A multicenter machine learning development and validation study
Le 17 octobre 2026
PLOS Digit Health. 2026 Oct 8;5(10):e0001637. doi: 10.1371/journal.pdig.0001637. eCollection 2026 Oct. ABSTRACT Timely detection is crucial to improve outcomes in patients with cardiac amyloidosis …
-
Cardiac amyloidosis: what every interventional cardiologist should know
Le 17 octobre 2026
Cardiovasc Interv Ther. 2026 Oct 8. doi: 10.1007/s12928-026-01358-z. Online ahead of print. ABSTRACT Cardiac amyloidosis (CA) is increasingly encountered by interventional cardiologists during the…
-
Cardiac amyloidosis and coronary artery disease: an overlooked clinical intersection
Le 17 octobre 2026
Coron Artery Dis. 2026 Sep 29. doi: 10.1097/MCA.0000000000001679. Online ahead of print. ABSTRACT Cardiac amyloidosis has emerged as an important and underrecognized cause of heart failure with…
-
Demographic Representation in Clinical Trials for Transthyretin-Associated Cardiac Amyloidosis: A Systematic Review
Le 17 octobre 2026
Rev Cardiovasc Med. 2026 Sep 8;27(9):53698. doi: 10.31083/RCM53698. eCollection 2026 Sep. ABSTRACT BACKGROUND: Underrepresentation of minority groups in clinical trials exacerbates health disparities…
Diagnostic et évaluation
-
Screening Criteria for Amyloidosis Biopsy Testing during Carpal Tunnel Release in Community Hospitals: Evaluation and Application
Le 17 octobre 2026
J Wrist Surg. 2025 Oct 14;15(5):459-464. doi: 10.1055/a-2710-9610. eCollection 2026 Oct. ABSTRACT BACKGROUND: Carpal tunnel syndrome (CTS) is a common disorder caused by median nerve compression…
-
Clinical manifestations and cardiac abnormalities in systemic Amyloid A Amyloidosis
Le 17 octobre 2026
Int J Cardiol. 2026 Oct 8:134973. doi: 10.1016/j.ijcard.2026.134973. Online ahead of print. ABSTRACT BACKGROUND: Cardiac involvement in systemic amyloid A (AA) amyloidosis is traditionally considered…
-
AA amyloidosis as a rare presentation leading to the diagnosis of mevalonate kinase deficiency in a male adult: a diagnostic challenge mimicking familial Mediterranean fever
Le 17 octobre 2026
Clin Exp Rheumatol. 2026 Oct 9. doi: 10.55563/clinexprheumatol/0rs4nj. Online ahead of print. NO ABSTRACT PMID: 42873706 | DOI: 10.55563/clinexprheumatol/0rs4nj
-
Pulmonary Amyloidosis Diagnosed by Transbronchial Lung Biopsy: A Three-Case Series With Diverse Radiological Manifestations
Le 17 octobre 2026
Respirol Case Rep. 2026 Sep 15;14(9):e70757. doi: 10.1002/rcr2.70757. eCollection 2026 Sep. ABSTRACT Pulmonary amyloidosis is a rare disease with diverse radiological manifestations that may mimic…
-
INSIGHT Model: Explainable Artificial Intelligence for Real-World EHR-Based Screening of Transthyretin Amyloidosis Cardiomyopathy
Le 10 septembre 2026
JACC Adv. 2026 Aug 17:103122. doi: 10.1016/j.jacadv.2026.103122. Online ahead of print. ABSTRACT BACKGROUND: Transthyretin amyloidosis (ATTR) diagnoses are frequently delayed or missed, attenuating…
-
Systemic amyloidosis diagnosed by labial salivary gland biopsy
Le 10 septembre 2026
BMJ Case Rep. 2026 Sep 1;19(9):e270079. doi: 10.1136/bcr-2025-270079. ABSTRACT A patient in his 60s presented to the local emergency department with symptoms of acute decompensating heart failure…
-
Susceptibility and screening approaches in systemic amyloidosis: expert perspectives from the International Society of Amyloidosis (ISA)
Le 10 septembre 2026
Amyloid. 2026 Sep 4:1-14. doi: 10.1080/13506129.2026.2718204. Online ahead of print. ABSTRACT BACKGROUND: Systemic amyloidosis is a progressive disease in which misfolded protein toxicity and…
-
The role of "red flags" in the diagnostic work-up of hereditary transthyretin amyloidosis: a study using a machine-learning approach
Le 10 septembre 2026
Neurol Sci. 2026 Aug 12;47(9):705. doi: 10.1007/s10072-026-09285-w. ABSTRACT INTRODUCTION: Hereditary transthyretin amyloidosis (ATTRv) is a rare progressive, potentially life-threatening multisystem…
-
Imaging Cardiac Amyloidosis: From Early Diagnosis to Risk Stratification and Evaluation of Treatment Efficacy
Le 10 septembre 2026
J Cardiovasc Dev Dis. 2026 Aug 21;13(8):401. doi: 10.3390/jcdd13080401. ABSTRACT Cardiac amyloidosis (CA) is an infiltrative cardiomyopathy caused by extracellular deposition of misfolded proteins,…
Interventions et pronostic
-
Emerging therapies and translational tools for drug development in systemic amyloidosis: insights from the International Society of Amyloidosis Scientific Workshop
Le 17 octobre 2026
Amyloid. 2026 Oct 5:1-14. doi: 10.1080/13506129.2026.2735581. Online ahead of print. ABSTRACT BACKGROUND: Amyloidosis is caused by deposition of misfolded proteins as amyloid fibrils in multiple…
-
Rapid therapeutic response in refractory lichen amyloidosis treated with upadacitinib: a case report
Le 17 octobre 2026
Front Med (Lausanne). 2026 Sep 22;13:1932492. doi: 10.3389/fmed.2026.1932492. eCollection 2026. ABSTRACT Lichen amyloidosis (LA) is an intractable, chronic pruritic skin disorder characterized by…
-
From limited options to therapeutic innovation: the changing landscape of transthyretin amyloidosis
Le 17 octobre 2026
Eur J Hosp Pharm. 2026 Sep 29:ejhpharm-2026-005372. doi: 10.1136/ejhpharm-2026-005372. Online ahead of print. NO ABSTRACT PMID: 42810846 | DOI: 10.1136/ejhpharm-2026-005372
-
Eplontersen for the Treatment of Hereditary Transthyretin Amyloidosis
Le 17 octobre 2026
Methods Mol Biol. 2026;3065:137-147. doi: 10.1007/978-1-0716-5476-7_8. ABSTRACT Hereditary transthyretin-mediated amyloidosis (ATTRv) is an autosomal dominant disease and the most common form of…
-
Neurohormonal Therapy in Patients With Transthyretin Cardiac Amyloidosis: Is it an Option?
Le 17 octobre 2026
JACC Case Rep. 2026 Sep 23;31(38):110244. doi: 10.1016/j.jaccas.2026.110244. ABSTRACT BACKGROUND: Neurohormonal therapy is strongly recommended for heart failure with reduced left ventricular…
Expériences des patients et des institutions
-
The pathophysiology of wild-type transthyretin amyloidosis: implications for exercise intolerance
Le 17 octobre 2026
Am J Physiol Heart Circ Physiol. 2026 Nov 1;331(5):H1530-H1545. doi: 10.1152/ajpheart.00430.2026. Epub 2026 Sep 18. ABSTRACT Wild-type transthyretin amyloidosis (ATTRwt) is an age-associated protein…
-
Amyloidosis & Advanced Heart Failure: When to Consider Cardiac Transplantation and What are the Results?
Le 10 septembre 2026
Curr Heart Fail Rep. 2026 Sep 8;23(1):44. doi: 10.1007/s11897-026-00777-6. ABSTRACT PURPOSE OF REVIEW: The management of end-stage heart failure in cardiac amyloidosis due to both light chain (AL-CA)…
-
Psycho-Emotional Profile and Disease Burden in Wild-Type Transthyretin Amyloidosis
Le 10 septembre 2026
J Clin Med. 2026 Aug 17;15(16):6348. doi: 10.3390/jcm15166348. ABSTRACT Background/Objectives: Patients with transthyretin amyloidosis frequently experience reduced quality of life, distress, anxiety…
-
In-Hospital Outcomes of Sepsis Hospitalizations Among Patients With Cardiac Amyloidosis: A 2022 National Inpatient Sample Analysis
Le 6 août 2026
Curr Probl Cardiol. 2026 Jul 18:103404. doi: 10.1016/j.cpcardiol.2026.103404. Online ahead of print. ABSTRACT BACKGROUND: Cardiac amyloidosis is characterized by restrictive physiology and limited…
